Jens Nielsen
Vorstandsvorsitzender bei Bioinnovation Institute
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Lena Treschow-Torell | M | 78 |
Chalmers University of Technology
| - |
Jan Orwar | M | 60 |
Chalmers University of Technology
| - |
Francesco Gatto | M | - |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 Jahre |
Martin N. Bonde | M | 61 |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen.
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | - |
Andreas Fhager | M | 48 |
Chalmers University of Technology
| - |
Shomit Ghose | M | 63 |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen. | 5 Jahre |
Sofia Hasselberg | M | 41 |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 2 Jahre |
Margareta Elisabeth Björk | M | 62 |
Chalmers University of Technology
| - |
Kent Viitanen | M | 59 |
Chalmers University of Technology
| - |
Vincent Desmaris | M | 47 |
Chalmers University of Technology
| - |
Christoph Langhammer | M | - |
Chalmers University of Technology
| - |
Tomas Arne Kåberger | M | 63 |
Chalmers University of Technology
| - |
Tatsiana Lobovkina | M | 49 |
Chalmers University of Technology
| - |
Thomas Schäfer | M | 61 |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen. | - |
Thomas Emanuelsson | M | 66 |
Chalmers University of Technology
| - |
Nadine Geiser | M | - |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen. | 3 Jahre |
Karl Bergman | M | - |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | - |
Paul Gatenholm | M | - |
Chalmers University of Technology
| - |
Johan Jianying Liu | M | 64 |
Chalmers University of Technology
| - |
Anette Larsson | F | - |
Chalmers University of Technology
| - |
Anders Kinnander | M | - |
Chalmers University of Technology
| - |
Gundel Tora Gunilla Jönson | M | 81 |
Chalmers University of Technology
| - |
Bengt Arne Sjöqvist | M | 72 |
Chalmers University of Technology
| - |
Pontus Ottosson | M | 49 |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 Jahre |
Jan Anders Vedin | M | 82 |
Chalmers University of Technology
| - |
Lars Håkan Larsson | M | 77 |
Chalmers University of Technology
| 24 Jahre |
Sten Scheibye | M | 72 |
Bioinnovation Institute
Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a Danish company that offers entrepreneurs and researchers in life science. The company is based in Copenhagen, Denmark. The CEO of the company is Jens Nielsen. | - |
Mats Johan Widerberg | M | 75 |
Chalmers University of Technology
| 11 Jahre |
Birgit Wøidemann Nørgaard | F | 65 |
Technical University of Denmark
| 19 Jahre |
Tomas Olovsson | M | - |
Chalmers University of Technology
| - |
Anders Olof Adolf Ekblom | M | 70 |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 6 Jahre |
Roger Flanagan | M | 80 |
Chalmers University of Technology
| - |
Enno Abel | M | - |
Chalmers University of Technology
| - |
Per Orvar Stenström | M | - |
Chalmers University of Technology
| - |
Per Johan Martin Andersson | M | 50 |
Chalmers University of Technology
| - |
Matts Andersson | M | 76 |
Chalmers University of Technology
| - |
Jonas Jendi | M | 54 |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 4 Jahre |
Claes Gösta Bankvall | M | - |
Chalmers University of Technology
| - |
Jan Peter Enoksson | M | 67 |
Chalmers University of Technology
| 23 Jahre |
Johan Stahre | M | - |
Chalmers University of Technology
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Henrik Blou | M | 45 |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | - |
Bo Stenhuus | M | - |
Technical University of Denmark
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | 5 Jahre |
Torsten Hoybye Regueira | M | - |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | 6 Jahre |
Thomas Grotkjær | M | - |
Technical University of Denmark
| 5 Jahre |
Jacob Thaysen | M | 49 |
Technical University of Denmark
| 4 Jahre |
Mikkel Høyerby | M | - |
Technical University of Denmark
| 5 Jahre |
Jochen Förster | M | - |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | 11 Jahre |
Henrik Kristian Moltke | M | 66 |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Torsten Kolind | M | - |
Technical University of Denmark
| 6 Jahre |
Willem Adriaan de Jongh | M | - |
Technical University of Denmark
| 3 Jahre |
Jamal El-Mosleh | M | 43 |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 4 Jahre |
Guggi Heine Remme Kofod | M | - |
Technical University of Denmark
| 3 Jahre |
Patrick Borre Hansen | M | - |
Technical University of Denmark
| 3 Jahre |
Kasper Møller | M | - |
Technical University of Denmark
| 3 Jahre |
Christina Sørensen | F | 52 |
Technical University of Denmark
| 6 Jahre |
Thomas Rantzau | M | 52 |
Technical University of Denmark
| 4 Jahre |
Már Erlingsson | M | 55 |
Technical University of Denmark
| 1 Jahre |
Andrias Petersen | M | 51 |
Technical University of Denmark
| 4 Jahre |
Arnstein Norheim | M | - |
Technical University of Denmark
| 1 Jahre |
Knud Christian Luxhøj | M | - |
Technical University of Denmark
| 2 Jahre |
Tommaso Breschi | M | - |
Technical University of Denmark
| 3 Jahre |
Zhang XI Sean | M | - |
Technical University of Denmark
| - |
Mikael Oerum | M | - |
Technical University of Denmark
| 10 Jahre |
Thomas Rasmussen | M | - |
Technical University of Denmark
| 5 Jahre |
Guy Zinman | M | - |
Technical University of Denmark
| 2 Jahre |
Saad Akram | M | - |
Technical University of Denmark
| 4 Jahre |
Gang Xiao | M | 62 |
Technical University of Denmark
| 6 Jahre |
Dorthe Lybye | M | 52 |
Technical University of Denmark
| 3 Jahre |
Mads Bjørnhof | M | - |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Leif Kongerslev | M | 71 |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Peter Bisgaard | M | 50 |
Technical University of Denmark
| 1 Jahre |
Isabelle de Cremoux | F | 54 |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
John Riis Mortensen | M | - |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Jeremy Taylor | M | - |
Technical University of Denmark
| - |
Claude J. Stoufs | M | 73 |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Palle Schelde Jensen | M | - |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Jean-Michel Hotton | M | - |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Henning Lorentzen | M | - |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Frank Knudsen | M | 66 |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | - |
Bo Stig Hansen | M | - |
Technical University of Denmark
| 13 Jahre |
Sami Kalevi Sassi | M | - |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | - |
Lars Christian Pallesen | M | 76 |
Technical University of Denmark
| 10 Jahre |
Ólafur Sörli Kristmundsson | M | - |
Technical University of Denmark
| 1 Jahre |
Jon Bondebjerg | M | - |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | - |
Henrijette Richter | M | 53 |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | - |
Casper Breum | M | 57 |
Technical University of Denmark
| 2 Jahre |
Tommy Bysted | M | - |
Technical University of Denmark
| 3 Jahre |
Katja N. Olsen | M | - |
Technical University of Denmark
| 4 Jahre |
Steen Meier Knudsen | M | 63 |
Technical University of Denmark
| 2 Jahre |
Poul Rødbroe Rasmussen | M | - |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | - |
Valdemar Warburg | M | - |
Technical University of Denmark
| 6 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Dänemark | 56 | 61,54% |
Schweden | 35 | 38,46% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jens Nielsen
- Persönliches Netzwerk